Companies:
10,651
total market cap:
$139.941 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
IDEX
IEX
#1469
Rank
$14.94 B
Marketcap
๐บ๐ธ
United States
Country
$198.55
Share price
-0.59%
Change (1 day)
-10.81%
Change (1 year)
IDEX Corporation
, is an American company founded in 1988 that develops, designs and manufactures fluidic systems and specialty technical handling.
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
IDEX
Quarterly Reports (10-Q)
Submitted on 2009-11-04
IDEX - 10-Q quarterly report FY
Text size:
Small
Medium
Large
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2009
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number 1-10235
IDEX CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
36-3555336
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
630 Dundee Road, Northbrook, Illinois
(Address of principal executive offices)
60062
(Zip Code)
Registrants telephone number: (847) 498-7070
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
þ
No
o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes
o
No
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
þ
Accelerated filer
o
Non-accelerated
filer
o
Smaller reporting company
o
(Do not check if a smaller reporting company)
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
o
No
þ
Number of shares of common stock of IDEX Corporation outstanding as of October 30, 2009: 80,827,210 (net of treasury shares).
TABLE OF CONTENTS
Part I.
Financial Information
Item 1.
Financial Statements.
1
Condensed Consolidated Balance Sheets
1
Condensed Consolidated Statements of Operations
2
Condensed Consolidated Statements of Shareholders Equity
3
Condensed Consolidated Statements of Cash Flows
4
Notes to Condensed Consolidated Financial Statements
5
Item 2.
Managements Discussion and Analysis of Financial Condition and Results of Operations
20
Cautionary Statement Under the Private Securities Litigation Reform Act
20
Historical Overview
20
Results of Operations
20
Liquidity and Capital Resources
25
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
26
Item 4.
Controls and Procedures
27
Part II. Other Information
Item 1
.
Legal Proceedings
28
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
28
Item 5.
Other Information
28
Item 6.
Exhibits
28
Signatures
29
Exhibit Index
30
EX-31.1
EX-31.2
EX-32.1
EX-32.2
Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements.
IDEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands except share and per share amounts)
(unaudited)
September 30, 2009
December 31, 2008_
ASSETS
Current assets
Cash and cash equivalents
$
74,429
$
61,353
Receivables, less allowance for doubtful accounts of $6,798 at September 30, 2009 and $5,600 at December 31, 2008
189,417
205,269
Inventories
162,384
181,200
Other current assets
32,363
32,866
Total current assets
458,593
480,688
Property, plant and equipment net
181,006
186,283
Goodwill
1,186,156
1,167,063
Intangible assets net
288,396
303,226
Other noncurrent assets
8,692
14,540
Total assets
$
2,122,843
$
2,151,800
LIABILITIES AND SHAREHOLDERS EQUITY
Current liabilities
Trade accounts payable
$
76,321
$
87,304
Accrued expenses
114,676
117,186
Short-term borrowings
6,307
5,856
Dividends payable
9,554
9,523
Total current liabilities
206,858
219,869
Long-term borrowings
440,832
548,144
Deferred income taxes
146,857
141,984
Other noncurrent liabilities
91,920
97,020
Total liabilities
886,467
1,007,017
Commitment and contingencies
Shareholders equity
Preferred stock:
Authorized: 5,000,000 shares, $.01 per share par value; Issued: None
Common stock:
Authorized: 150,000,000 shares, $.01 per share par value
Issued: 83,277,330 shares at September 30, 2009 and 82,786,045 shares at December 31, 2008
833
828
Additional paid-in capital
393,832
377,154
Retained earnings
873,590
822,286
Treasury stock at cost: 2,537,538 shares at September 30, 2009 and 2,483,955 shares at December 31, 2008
(56,597
)
(55,393
)
Accumulated other comprehensive income (loss)
24,718
(92
)
Total shareholders equity
1,236,376
1,144,783
Total liabilities and shareholders equity
$
2,122,843
$
2,151,800
See Notes to Condensed Consolidated Financial Statements.
1
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands except per share amounts)
(unaudited)
Three Months Ended
Nine Months Ended
September 30,
September 30,
2009
2008
2009
2008
Net sales
$
323,249
$
365,193
$
986,317
$
1,134,165
Cost of sales
194,191
217,409
602,964
672,391
Gross profit
129,058
147,784
383,353
461,774
Selling, general and administrative expenses
79,789
81,614
242,687
258,082
Goodwill impairment
30,090
30,090
Restructuring expenses
2,752
5,276
8,253
5,276
Operating income
46,517
30,804
132,413
168,326
Other income net
1,382
2,723
806
3,885
Interest expense
3,951
3,861
13,212
13,619
Income before income taxes
43,948
29,666
120,007
158,592
Provision for income taxes
14,171
9,783
39,703
54,046
Net income
$
29,777
$
19,883
$
80,304
$
104,546
Basic earnings per common share
$
0.37
$
0.24
$
1.00
$
1.27
Diluted earnings per common share
$
0.37
$
0.24
$
0.99
$
1.26
Share data:
Basic weighted average common shares outstanding
79,740
81,572
79,642
81,320
Diluted weighted average common shares outstanding
80,879
82,957
80,535
82,663
See Notes to Condensed Consolidated Financial Statements.
2
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
(in thousands except share and per share amounts)
(unaudited)
Accumulated Other Comprehensive Income (Loss)
Net
Actuarial
Losses
and Prior
Service
Costs on
Pensions
Cumulative
and Other
Unrealized
Common Stock
Post-
Losses
and Additional
Cumulative
Retirement
on Derivatives
Total
Paid-In
Retained
Translation
Benefit
Designated as Cash
Treasury
Shareholders
Capital
Earnings
Adjustment
Plans
Flow Hedges
Stock
Equity
Balance, December 31, 2008, as previously stated
$
377,982
$
845,396
$
39,873
$
(33,654
)
$
(6,642
)
$
(55,393
)
$
1,167,562
Impact of adopting change in accounting related to inventory (see Note 5)
(23,110
)
331
(22,779
)
Balance, December 31, 2008, as restated
$
377,982
$
822,286
$
40,204
$
(33,654
)
$
(6,642
)
$
(55,393
)
$
1,144,783
Net income
80,304
80,304
Other comprehensive income, net of tax:
Cumulative translation adjustment
23,558
23,558
Amortization of retirement obligations
1,702
1,702
Unrealized gain on derivatives designated as cash flow hedges
(450
)
(450
)
Other comprehensive income
24,810
Comprehensive income
105,114
Issuance of 238,388 shares of common stock from exercise of stock options and deferred compensation plans, net of tax benefit
3,902
3,902
Share-based compensation
12,781
12,781
Unvested shares surrendered for tax withholding
(1,204
)
(1,204
)
Cash dividends declared $.36 per common share
(29,000
)
(29,000
)
Balance, September 30, 2009
$
394,665
$
873,590
$
63,762
$
(31,952
)
$
(7,092
)
$
(56,597
)
$
1,236,376
See Notes to Condensed Consolidated Financial Statements.
3
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Nine Months
Ended
September 30,
2009
2008
Cash flows from operating activities
Net income
$
80,304
$
104,546
Adjustments to reconcile net income to net cash provided by operating activities:
Loss on sale of fixed assets
447
Goodwill impairment
30,090
Depreciation and amortization
23,482
23,468
Amortization of intangible assets
18,411
11,624
Amortization of debt issuance expenses
232
214
Stock-based compensation expense
12,781
12,423
Deferred income taxes
4,302
(9,183
)
Excess tax benefit from stock-based compensation
(1,523
)
(2,911
)
Changes in (net of the effect from acquisitions):
Receivables
20,100
4,818
Inventories
20,774
(4,643
)
Trade accounts payable
(12,762
)
(243
)
Accrued expenses
(9,005
)
1,291
Other net
131
(3,381
)
Net cash flows provided by operating activities
157,674
168,113
Cash flows from investing activities
Additions to property, plant and equipment
(18,346
)
(19,104
)
Acquisition of businesses, net of cash acquired
(156,180
)
Proceeds from fixed assets disposals
3,582
Change in restricted cash
140,005
Other net
329
Net cash flows used in investing activities
(14,435
)
(35,279
)
Cash flows from financing activities
Borrowings under credit facilities
64,906
446,925
Payments under credit facilities
(174,203
)
(279,278
)
Payment of senior notes
(150,000
)
Dividends paid
(28,969
)
(29,496
)
Proceeds from stock option exercises
3,692
9,407
Excess tax benefit from stock-based compensation
1,523
2,911
Other net
(1,204
)
(950
)
Net cash flows used in financing activities
(134,255
)
(481
)
Effect of exchange rate changes on cash and cash equivalents
4,092
(1,133
)
Net increase in cash
13,076
131,220
Cash and cash equivalents at beginning of year
61,353
102,757
Cash and cash equivalents at end of period
$
74,429
$
233,977
Supplemental cash flow information
Cash paid for:
Interest
$
13,400
$
15,275
Income taxes
31,853
58,623
Significant non-cash activities:
Capital expenditures included in accounts payable
432
621
Issuance of unvested shares
4,895
See Notes to Condensed Consolidated Financial Statements.
4
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1.
Basis of Presentation and Significant Accounting Policies
The Condensed Consolidated Financial Statements of IDEX Corporation (IDEX or the Company) have been prepared in accordance with the instructions to
Form 10-Q
under the Securities Exchange Act of 1934, as amended. The statements are unaudited but include all adjustments, consisting only of recurring items, except as noted, which the Company considers necessary for a fair presentation of the information set forth herein. The results of operations for the three and nine months ended September 30, 2009 are not necessarily indicative of the results to be expected for the entire year.
The condensed consolidated financial statements and Managements Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Companys Annual Report on
Form 10-K
for the fiscal year ended December 31, 2008.
Adoption of New Accounting Standards
On July 1, 2009 the Financial Accounting Standards Board (FASB) Accounting Standards Codification
tm
(ASC) became the authoritative source of accounting principals to be applied to financial statements prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP). In accordance with the ASC, citations to accounting literature in this report are to the relevant topic of the ASC or are presented in plain English. This standard is effective for financial statements issued for interim and annual periods ending after September 15, 2009. The Company adopted this standard at its effective date.
In May 2009, the FASB issued an update to ASC 855 Subsequent Events. This standard establishes general standards of accounting for and disclosure of events that occur after the balance sheet date, but before the financial statements are issued or available to be issued (subsequent events). This standard requires disclosure of the date through which the entity has evaluated subsequent events and the basis for that date. For public entities, this is the date the financial statements are issued. This standard does not apply to subsequent events or transactions that are within the scope of other GAAP and will not result in significant changes in the subsequent events reported by the Company. This standard is effective for interim or annual periods ending after June 15, 2009. The Company has adopted this standard at its effective date.
In April 2009, the FASB issued an update to ASC 820 Fair Value Measurements and Disclosures and ASC 270 Interim Reporting. This standard requires disclosures about fair value of financial instruments in interim and annual financial statements. This standard is effective for periods ending after June 15, 2009. The Company has adopted this standard at its effective date.
In June 2008, the FASB issued an update to ASC 260, Earnings Per Share. This standard addresses whether instruments granted in share-based payment transactions are participating securities prior to vesting and, therefore, need to be included in the allocation in computing earnings per share under the two-class method described in FASB ASC 260, Earnings Per Share. The FASB concluded that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding unvested shares are participating securities. Accordingly, effective January 1, 2009, earnings per common share are computed using the two-class method prescribed by ASC 260. All previously reported earnings per common share data has been retrospectively adjusted to conform to the new computation method (see Note 4).
In December 2007, the FASB issued an update to ASC 805 Business Combinations. The objective of the standard is to establish principles and requirements for how an acquirer in a business combination recognizes and measures in its financial statements, the identifiable assets acquired, the liabilities assumed, and any controlling interest; recognizes and measures the goodwill acquired in the business combination or a gain from a bargain purchase; and determines what information to disclose to enable users of the financial statements to evaluate the
5
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
nature and financial effects of the business combination. This standard is to be applied prospectively to business combinations for which the acquisition date is on or after an entitys fiscal year that begins after December 15, 2008. The Company will adopt this standard for all future acquisitions.
In December 2007, the FASB issued an update to ASC 810 Consolidation. The objective of the standard is to change the financial accounting and reporting for noncontrolling (or minority) interests in consolidated financial statements. The provisions of this standard in part; establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary; clarifies that a noncontrolling interest in a subsidiary is an ownership interest in the consolidated entity that should be reported as equity in the consolidated financial statements; establishes a single method of accounting for changes in a parents ownership interest in a subsidiary that do not result in deconsolidation; requires that a parent recognize a gain or loss in net income when a subsidiary is deconsolidated; and requires expanded disclosures in the consolidated financial statements that clearly identify and distinguish between the interests of the parents owners and the interests of the noncontrolling owners of a subsidiary. ASC 810 is effective for fiscal years, and interim periods within those fiscal years, beginning on or after December 15, 2008. The adoption of this standard effective January 2009 did not have an effect on the consolidated financial position, results of operations or cash flows of the Company.
Inventory
As of January 1, 2009, the Company changed its method for accounting for certain inventories from
last-in,
first-out (LIFO) to
first-in,
first-out (FIFO). The company applied this change in accounting principle retrospectively in accordance with FASB ASC 250, Accounting Changes and Error Corrections (see Note 5).
2.
Restructuring
During the past five quarters, we have recorded restructuring costs as a result of cost reduction efforts and facility closings. Accruals have been recorded based on these costs and primarily consist of employee termination benefits. We record accruals for employee termination benefits based on the guidance of FASB ASC 420, Exit or Disposal Cost Obligations. These expenses are included in Restructuring expenses in the Condensed Consolidated Statement of Operations while the restructuring accruals are included in Accrued expenses in our Condensed Consolidated Balance Sheets.
2009 Initiatives
During the three and nine months ended September 30, 2009, the Company recorded pre-tax restructuring expenses totaling $2.8 million and $8.3 million, respectively, for employee severance related to employee reductions across various functional areas as well as facility closures resulting from the Companys cost savings initiatives. These initiatives included severance benefits for 384 employees. The Company is anticipating the employee reductions to be completed by the end of 2009 with an expected additional total cost of $2.0 $3.0 million during the fourth quarter, with severance payments expected to be fully paid by the end of 2010 using cash from operations.
2008 Initiatives
For the full year 2008, the Company recorded pre-tax restructuring expenses totaling $18.0 million for employee severance related to employee reductions across various functional areas as well as facility closures resulting from our cost savings initiatives. These initiatives included severance benefits for 380 employees. These employee reductions were completed by the end of 2008, with severance payments expected to be fully paid by the end of 2009 using cash from operations.
6
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Pre-tax restructuring expenses, by segment for the three months ended September 30, 2009, were as follows:
Asset
Write-downs
Severance
& Exit
Costs
Costs
Total
(in thousands)
Fluid & Metering Technologies
$
657
$
$
657
Health & Science Technologies
841
184
1,025
Dispensing Equipment
630
630
Fire & Safety/Diversified Products
24
24
Corporate/Other
202
214
416
Total restructuring costs
$
2,354
$
398
$
2,752
Pre-tax restructuring expenses, by segment for the nine months ended September 30, 2009, were as follows:
Asset
Write-downs
Severance
& Exit
Costs
Costs
Total
(in thousands)
Fluid & Metering Technologies
$
2,552
$
490
$
3,042
Health & Science Technologies
2,123
596
2,719
Dispensing Equipment
347
860
1,207
Fire & Safety/Diversified Products
474
474
Corporate/Other
441
370
811
Total restructuring costs
$
5,937
$
2,316
$
8,253
Restructuring accruals of $9.3 million at both September 30, 2009 and December 31, 2008, respectively, are reflected in Accrued expenses in our Condensed Consolidated Balance Sheets as follows:
2008
2009
Initiatives
Initiatives
Total
(in thousands)
Balance at January 1, 2009
$
9,263
$
$
9,263
Restructuring costs/reversals
828
7,425
8,253
Acquisition related
3,927
3,927
Payments/utilization
(7,279
)
(4,894
)
(12,173
)
Balance at September 30, 2009
$
2,812
$
6,458
$
9,270
3.
Business Segments
The Company consists of four reportable segments: Fluid & Metering Technologies, Health & Science Technologies, Dispensing Equipment and Fire & Safety/Diversified Products.
The Fluid & Metering Technologies Segment produces pumps, flow meters, and related controls for the movement of liquids and gases in a diverse range of end markets from industrial infrastructure to food and beverage. The Health & Science Technologies Segment produces a wide variety of small-scale, highly accurate pumps, valves, fittings and medical devices, as well as compressors used in medical, dental and industrial applications. The Dispensing Equipment Segment produces highly engineered equipment for dispensing, metering and mixing colorants, paints, inks and dyes, refinishing equipment, as well as the food industry. The Fire & Safety/Diversified Products Segment produces firefighting pumps, rescue tools, lifting bags and other components and systems for the
7
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
fire and rescue industry, as well as engineered stainless steel banding and clamping devices used in a variety of industrial and commercial applications.
Information on the Companys business segments is presented below, based on the nature of products and services offered. The Company evaluates performance based on several factors, of which operating income is the primary financial measure. Intersegment sales are accounted for at fair value as if the sales were to third parties.
Three Months
Nine Months
Ended
Ended
September 30,
September 30,
2009
2008
2009
2008
(In thousands)
Net sales
Fluid & Metering Technologies:
External customers
$
156,781
$
169,957
$
470,271
$
517,641
Intersegment sales
158
301
686
905
Total group sales
156,939
170,258
470,957
518,546
Health & Science Technologies:
External customers
75,365
82,506
219,305
251,279
Intersegment sales
773
383
4,837
2,499
Total group sales
76,138
82,889
224,142
253,778
Dispensing Equipment:
External customers
25,580
31,543
104,111
138,152
Intersegment sales
Total group sales
25,580
31,543
104,111
138,152
Fire & Safety/Diversified Products:
External customers
65,523
81,187
192,630
227,093
Intersegment sales
1
2
3
6
Total group sales
65,524
81,189
192,633
227,099
Intersegment elimination
(932
)
(686
)
(5,526
)
(3,410
)
Total net sales
$
323,249
$
365,193
$
986,317
$
1,134,165
Operating income (loss)
Fluid & Metering Technologies
$
25,755
$
33,656
$
70,731
$
98,227
Health & Science Technologies
14,287
17,012
34,703
47,896
Dispensing Equipment
(1)
(311
)
(32,026
)
13,112
(6,526
)
Fire & Safety/Diversified Products
15,932
20,401
42,790
56,959
Corporate office and other
(9,146
)
(8,239
)
(28,923
)
(28,230
)
Total operating income
$
46,517
$
30,804
$
132,413
$
168,326
(1)
Segment operating income includes $30.1 million goodwill impairment charge in 2008 for Fluid Management Americas.
8
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
4.
Earnings Per Common Share
Earnings per common share (EPS) is computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents outstanding (diluted) during the period. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, unvested shares, and shares issuable in connection with certain deferred compensation agreements (DCUs).
ASC 260, Earnings Per Share, concludes that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Corporation is required to apply the two-class method of computing basic and diluted earnings per share. The Corporation has determined that its outstanding unvested shares are participating securities. Accordingly, effective January 1, 2009, earnings per common share are computed using the two-class method prescribed by ASC 260. All previously reported earnings per common share data has been retrospectively adjusted to conform to the new computation method. Net income attributable to common shareholders was reduced by $0.2 million and $0.1 million for the three months ended September 30, 2009 and 2008, respectively. Net income attributable to common shareholders was reduced by $0.6 million and $0.9 million for the nine months ended September 30, 2009 and 2008, respectively.
Basic weighted average shares reconciles to diluted weighted average shares as follows:
Three Months
Nine Months
Ended September 30,
Ended September 30,
2009
2008
2009
2008
(In thousands)
Basic weighted average common shares outstanding
79,740
81,572
79,642
81,320
Dilutive effect of stock options, unvested shares, and DCUs
1,139
1,385
893
1,343
Diluted weighted average common shares outstanding
80,879
82,957
80,535
82,663
Options to purchase approximately 2.5 million and 2.0 million shares of common stock as of September 30, 2009 and 2008, respectively, were not included in the computation of diluted EPS because the exercise price was greater than the average market price of the Companys common stock and, therefore, the effect of their inclusion would be antidilutive.
5.
Inventories
Inventories are stated at the lower of cost or market. Cost, which includes material, labor, and factory overhead, is determined on a FIFO basis.
9
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Prior to 2009, we valued certain inventories under the LIFO cost method. As of January 1, 2009, we changed our method of accounting for these inventories from the LIFO method to the FIFO method. As of December 31, 2008, the inventories for which the LIFO method of accounting was applied represented approximately 85% of total net inventories. We believe that this change is to a preferable method which better reflects the current cost of inventory on our consolidated balance sheets. Additionally, this change conforms all of our worldwide inventories to a consistent inventory costing method and provides better comparability to our peers. We applied this change in accounting principle retrospectively to all prior periods presented herein in accordance with FASB ASC 250, Accounting Changes and Error Corrections. As a result of this accounting change, our retained earnings as of December 31, 2008 decreased to $822.3 million using the FIFO method from $845.4 million as originally reported using the LIFO method. The following tables summarize the effect of the accounting change on our consolidated financial statements.
Three Months Ended
Three Months Ended
September 30, 2009
September 30, 2008
As
Computed
Effect
Computed
Effect
Under Prior
of
Under
Originally
of
As
Method
Change
FIFO
Reported
Change
Adjusted
(Thousands, except per share data)
Statement of Operations:
Cost of sales
$
194,794
$
(603
)
$
194,191
$
218,796
$
(1,387
)
$
217,409
Income taxes
13,954
217
14,171
9,204
579
9,783
Net income
29,391
386
29,777
19,075
808
19,883
Per common share:
Basic earnings
0.36
0.01
0.37
0.23
0.01
0.24
Diluted earnings
0.36
0.01
0.37
0.23
0.01
0.24
Statement of Cash Flows:
Net income
29,391
386
29,777
19,075
808
19,883
Deferred income tax liability
(2,607
)
217
(2,390
)
(11,259
)
579
(10,680
)
Inventory working capital change
7,293
(603
)
6,690
2,232
(1,527
)
705
Net cash provided by operating activities
84,763
84,763
72,836
72,836
Nine Months Ended
Nine Months Ended
September 30, 2009
September 30, 2008
As
Computed
Effect
Computed
Effect
Under Prior
of
Under
Originally
of
As
Method
Change
FIFO
Reported
Change
Adjusted
(Thousands, except per share data)
Statement of Operations:
Cost of sales
$
600,119
$
2,845
$
602,964
$
669,393
$
2,998
$
672,391
Income taxes
40,645
(942
)
39,703
55,082
(1,036
)
54,046
Net income
82,207
(1,903
)
80,304
106,508
(1,962
)
104,546
Per common share:
Basic earnings
1.02
(0.02
)
1.00
1.31
(0.04
)
1.27
Diluted earnings
1.01
(0.02
)
0.99
1.29
(0.03
)
1.26
Statement of Cash Flows:
Net income
82,207
(1,903
)
80,304
106,508
(1,962
)
104,546
Deferred income tax liability
5,244
(942
)
4,302
(8,147
)
(1,036
)
(9,183
)
Inventory working capital change
17,929
2,845
20,774
(7,368
)
2,725
(4,643
)
Net cash provided by operating activities
157,674
157,674
168,113
168,113
10
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
September 30, 2009
December 31, 2008
Balance Sheet:
Inventories
$
198,189
$
(35,805
)
$
162,384
$
214,160
$
(32,960
)
$
181,200
Other current assets (prepaid taxes)
22,978
9,385
32,363
24,423
8,443
32,866
Accrued expenses (income tax payable)
114,062
614
114,676
116,572
614
117,186
Deferred income tax liability
149,209
(2,352
)
146,857
144,336
(2,352
)
141,984
Cumulative translation adjustment
63,500
262
63,762
39,873
331
40,204
Retained earnings
898,603
(25,013
)
873,590
845,396
(23,110
)
822,286
The revised components of inventories as of September 30, 2009 and December 31, 2008 were as follows:
September 30,
December 31,
2009
2008
(In thousands)
Raw materials and component parts
$
104,087
$
110,290
Work-in-process
20,345
22,483
Finished goods
37,952
48,427
Total
$
162,384
$
181,200
6.
Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for the nine months ended September 30, 2009, by reporting segment, were as follows:
Fluid &
Health &
Fire & Safety/
Metering
Science
Dispensing
Diversified
Technologies
Technologies
Equipment
Products
Total
(In thousands)
Balance at December 31, 2008
$
524,387
$
391,654
$
103,470
$
147,552
$
1,167,063
Foreign currency translation
8,428
496
2,993
2,515
14,432
Acquisition adjustments
3,657
1,004
4,661
Balance at September 30, 2009
$
536,472
$
393,154
$
106,463
$
150,067
$
1,186,156
For acquisitions completed in the fourth quarter of 2008, the Company is in the process of finalizing appraisals of tangible and intangible assets and is continuing to complete the purchase price allocations, which will be adjusted as additional information relative to the fair values of the assets and liabilities becomes known.
Acquisition adjustments during the nine months ended September 30, 2009 primarily relate to restructuring charges and other fair value adjustments of $4.3 million recorded by Richter Chemie-Technik, a business unit within the Companys Fluid & Metering Technologies Segment, offset by other various acquisition adjustments. The restructuring charges were primarily employee severance related to employee reductions across various functional areas.
ASC 350, Goodwill and Other Intangible Assets, requires that goodwill be tested for impairment at the reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. Annually on October 31
st
, goodwill and other acquired intangible assets with indefinite lives are tested for impairment. The Company concluded that the fair value of each of the reporting units was in excess of the carrying value as of
11
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
October 31, 2008. The Company did not consider there to be any triggering event that would require an interim impairment assessment, therefore none of the goodwill or other acquired intangible assets with indefinite lives were tested for impairment during the nine months ended September 30, 2009.
The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset as of September 30, 2009 and December 31, 2008:
September 30, 2009
December 31, 2008
Gross
Weighted
Gross
Carrying
Accumulated
Average
Carrying
Accumulated
Amount
Amortization
Lives
Amount
Amortization
(In thousands)
Amortizable intangible assets:
Patents
$
11,917
$
(6,048
)
11
$
11,795
$
(5,550
)
Trade names
64,078
(9,448
)
15
62,805
(6,310
)
Customer relationships
158,513
(28,577
)
12
156,216
(16,601
)
Non-compete agreements
4,276
(3,214
)
4
4,569
(2,989
)
Unpatented technology
36,093
(5,442
)
14
35,527
(2,939
)
Other
6,236
(2,088
)
10
6,282
(1,679
)
Total amortizable intangible assets
281,113
(54,817
)
277,194
(36,068
)
Banjo trade name
62,100
62,100
$
343,213
$
(54,817
)
$
339,294
$
(36,068
)
The Banjo trade name is an indefinite lived intangible asset which is tested for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the asset might be impaired.
7.
Accrued Expenses
The components of accrued expenses as of September 30, 2009 and December 31, 2008 were:
September 30,
December 31,
2009
2008
(In thousands)
Payroll and related items
$
47,053
$
45,162
Management incentive compensation
7,009
10,078
Income taxes payable
8,420
8,275
Deferred income taxes
847
1,469
Insurance
9,081
9,964
Warranty
4,304
3,751
Deferred revenue
4,201
2,600
Restructuring
9,270
9,263
Other
24,491
26,624
Total accrued expenses
$
114,676
$
117,186
12
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
8.
Borrowings
Borrowings at September 30, 2009 and December 31, 2008 consisted of the following:
September 30,
December 31,
2009
2008
(In thousands)
Credit Facility
$
347,664
$
448,763
Term Loan
95,000
100,000
Other borrowings
4,475
5,237
Total borrowings
447,139
554,000
Less current portion
6,307
5,856
Total long-term borrowings
$
440,832
$
548,144
The Company maintains a $600.0 million unsecured domestic, multi-currency bank revolving credit facility (Credit Facility), which expires on December 21, 2011. In 2008, the Credit Facility was amended to allow the Company to designate certain foreign subsidiaries as designated borrowers. Upon approval from the lenders, the designated borrowers were allowed to receive loans under the Credit Facility. A designated borrower sublimit was established as the lesser of the aggregate commitments or $100.0 million. As of the amendment date, Fluid Management Europe B.V., (FME) was approved by the lenders as a designated borrower. FMEs borrowings under the Credit Facility at September 30, 2009 were approximately $65.7 million (Euro 45.0 million). As the FME borrowings under the Credit Facility are Euro denominated and the cash flows that will be used to make payments of principal and interest are predominately denominated in Euros, the Company does not anticipate any significant foreign exchange gains or losses in servicing this debt.
At September 30, 2009 there was $347.7 million outstanding under the Credit Facility and outstanding letters of credit totaled approximately $7.1 million. The net available borrowing under the Credit Facility as of September 30, 2009, was approximately $245.2 million. Interest is payable quarterly on the outstanding borrowings at the bank agents reference rate. Interest on borrowings based on LIBOR plus an applicable margin is payable on the maturity date of the borrowing, or quarterly from the effective date for borrowings exceeding three months. The applicable margin is based on the Companys senior, unsecured, long-term debt rating and can range from 24 basis points to 50 basis points. Based on the Companys BBB rating at September 30, 2009, the applicable margin was 40 basis points. An annual Credit Facility fee, also based on the Companys credit rating, is currently 10 basis points and is payable quarterly.
At September 30, 2009 the Company had one interest rate exchange agreement related to the Credit Facility. The interest rate exchange agreement, expiring in January 2011, effectively converted $250.0 million of floating-rate debt into fixed-rate debt at an interest rate of 3.25%. The fixed rate noted above is comprised of the fixed rate on the interest rate exchange agreement and the Companys current margin of 40 basis points on the Credit Facility.
On April 18, 2008, the Company completed a $100.0 million unsecured senior bank term loan agreement (Term Loan) with covenants consistent with the existing Credit Facility and a maturity on December 21, 2011. At September 30, 2009, there was $95.0 million outstanding under the Term Loan with $5.0 million included within short term borrowings. Interest under the Term Loan is based on the bank agents reference rate or LIBOR plus an applicable margin and is payable at the end of the selected interest period, but at least quarterly. The applicable margin is based on the Companys senior, unsecured, long-term debt rating and can range from 45 to 100 basis points. Based on the Companys current debt rating, the applicable margin is 80 basis points. The Term Loan requires repayments of $5.0 million and $7.5 million in April of 2010 and 2011, respectively, with the remaining balance due on December 21, 2011. The Company used the proceeds from the Term Loan to pay down existing debt outstanding under the Credit Facility.
13
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
At September 30, 2009 the Company had an interest rate exchange agreement related to the Term Loan that expires December 2011. With a current notional amount of $95.0 million, the agreement effectively converted $100.0 million of floating-rate debt into fixed-rate debt at an interest rate of 4.00%. The fixed rate is comprised of the fixed rate on the interest rate exchange agreement and the Companys current margin of 80 basis points on the Term Loan.
9.
Derivative Instruments
ASC 815 Derivatives and Hedging, requires that a Company with derivative instruments disclose information to enable users of the financial statements to understand: how and why an entity uses derivative instruments; how derivative instruments and related hedged items are accounted for; and how derivative instruments and related hedged items affect an entitys financial position, financial performance, and cash flows. As such, ASC 815 requires qualitative disclosures about objectives and strategies for using derivatives, quantitative disclosures about fair value amounts of and gains and losses on derivative instruments, and disclosures about credit-risk-related contingent features in derivative agreements.
The Company enters into cash flow hedges to reduce the exposure to variability in certain expected future cash flows. The type of cash flow hedges the Company enters into includes foreign currency contracts and interest rate exchange agreements that effectively convert a portion of floating-rate debt to fixed-rate debt and are designed to reduce the impact of interest rate changes on future interest expense.
The effective portion of gains or losses on interest rate exchange agreements is reported in accumulated other comprehensive income in shareholders equity and reclassified into net income in the same period or periods in which the hedged transaction affects net income. The remaining gain or loss in excess of the cumulative change in the present value of future cash flows or the hedged item, if any, is recognized into net income during the period of change.
Fair values relating to derivative financial instruments reflect the estimated amounts that the Company would receive or pay to sell or buy the contracts based on quoted market prices of comparable contracts at each balance sheet date.
At September 30, 2009, the Company had two interest rate exchange agreements. The first interest rate exchange agreement, expiring in January 2011, effectively converted $250.0 million of floating-rate debt into fixed-rate debt at an interest rate of 3.25%. The second interest rate exchange agreement, expiring December 2011, with a current notional amount of $95.0 million, effectively converted $100.0 million of floating-rate debt into fixed-rate debt at an interest rate of 4.00%. The fixed rate is comprised of the fixed rate on the interest rate exchange agreements and the Companys current margin of 40 basis points for the Credit Facility and 80 basis points on the Term Loan.
Based on interest rates at September 30, 2009, approximately $9.3 million of the amount included in accumulated other comprehensive income (loss) in shareholders equity at September 30, 2009 will be recognized to net income over the next 12 months as the underlying hedged transactions are realized.
At September 30, 2009, the Company had foreign currency exchange contracts with an aggregate notional amount of $3.4 million to manage its exposure to fluctuations in foreign currency exchange rates. The change in fair market value of these contracts for the nine months ended September 30, 2009 was immaterial.
The following tables set forth the fair value amounts of derivative instruments held by the Company as of September 30, 2009 and December 31, 2008:
Fair Value-Assets
September 30,
December 31,
2009
2008
Balance Sheet Caption
(In thousands)
Foreign exchange contracts
$
452
$
Current assets
14
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Fair Value-Liabilities
September 30,
December 31,
2009
2008
Balance Sheet Caption
(In thousands)
Interest rate contracts
$
11,573
$
10,098
Other noncurrent liabilities
Foreign exchange contracts
272
Accrued expenses
$
11,573
$
10,370
The following tables summarize the gain (loss) recognized and the amounts and location of income (expense) and gain (loss) reclassified into income for interest rate contracts and foreign currency contracts as of September 30, 2009 and 2008:
Gain (Loss)
Income (Expense)
Recognized in
and Gain
Other
(Loss)
Comprehensive
Reclassified into
Income (Loss)
Income
Three Months Ended September 30,
Income
2009
2008
2009
2008
Statement Caption
(In thousands)
Interest rate contracts
$
(751
)
$
(234
)
$
(2,148
)
$
(158
)
Interest expense
Foreign exchange contracts
112
346
Sales
Gain (Loss)
Income (Expense)
Recognized in
and Gain
Other
(Loss)
Comprehensive
Reclassified into
Income (Loss)
Income
Income
Nine Months Ended September 30,
Statement
2009
2008
2009
2008
Caption
(In thousands)
Interest rate contracts
$
(943
)
$
2,922
$
(5,757
)
$
(106
)
Interest expense
Foreign exchange contracts
493
399
Sales
10.
Fair Value Measurements
ASC 820,
Fair Value Measurements and Disclosures
defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The standard utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:
Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.
Level 3: Unobservable inputs that reflect the reporting entitys own assumptions.
15
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
The following table summarizes the basis used to measure the Companys financial assets and liabilities at fair value on a recurring basis in the balance sheet at September 30, 2009 and December 31, 2008:
Basis of Fair Value Measurements
Balance at
September 30, 2009
Level 1
Level 2
Level 3
(In thousands)
Interest rate exchange agreement derivative financial instruments (included in Other noncurrent liabilities)
$
11,573
$
11,573
Foreign currency contracts (included in Other current assets)
$
452
$
452
Balance at
December 31, 2008
Level 1
Level 2
Level 3
(In thousands)
Interest rate exchange agreement derivative financial instruments (included in Other noncurrent liabilities)
$
10,098
$
10,098
Foreign currency contracts (included in Accrued expenses)
$
272
$
272
In determining the fair value of the Companys interest rate exchange agreement derivatives, the Company uses a present value of expected cash flows based on market observable interest rate yield curves commensurate with the term of each instrument and the credit default swap market to reflect the credit risk of either the Company or the counterparty.
The carrying value of our cash and cash equivalents, accounts receivable, and accounts payable approximates their fair values because of the short term nature of these instruments. At September 30, 2009, the fair value of our long term debt, based on the current market rates for debt with similar credit risk and maturity, approximated the value recorded on our balance sheet.
11.
Common and Preferred Stock
At September 30, 2009 and December 31, 2008, the Company had 150 million shares of authorized common stock, with a par value of $.01 per share and 5 million shares of preferred stock with a par value of $.01 per share. No preferred stock was issued as of September 30, 2009 and December 31, 2008.
12.
Share-Based Compensation
During the nine months ended September 30, 2009, the Company granted approximately 1.2 million stock options and 0.3 million unvested shares. During the nine months ended September 30, 2008, the Company granted approximately 1.1 million stock options and 0.6 million unvested shares.
16
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Total compensation cost for stock options is as follows:
Three Months
Nine Months
Ended September 30,
Ended September 30,
2009
2008
2009
2008
(In thousands)
Cost of goods sold
$
220
$
256
$
758
$
843
Selling, general and administrative expenses
1,455
1,772
5,109
5,786
Total expense before income taxes
1,675
2,028
5,867
6,629
Income tax benefit
(531
)
(645
)
(1,889
)
(2,102
)
Total expense after income taxes
$
1,144
$
1,383
$
3,978
$
4,527
Total compensation cost for unvested shares is as follows:
Three Months
Nine Months
Ended September 30,
Ended September 30,
2009
2008
2009
2008
(In thousands)
Cost of goods sold
$
63
$
24
$
187
$
55
Selling, general and administrative expenses
2,072
2,160
6,727
5,739
Total expense before income taxes
2,135
2,184
6,914
5,794
Income tax benefit
(384
)
(378
)
(1,167
)
(1,097
)
Total expense after income taxes
$
1,751
$
1,806
$
5,747
$
4,697
Classification of stock compensation cost within the Condensed Consolidated Statements of Operations is consistent with classification of cash compensation for the same employees, and compensation cost capitalized as part of inventory was immaterial.
As of September 30, 2009, there was $11.6 million of total unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.4 years, and $13.3 million of total unrecognized compensation cost related to unvested shares that is expected to be recognized over a weighted-average period of 1.2 years.
13.
Retirement Benefits
The Company sponsors several qualified and nonqualified defined benefit and defined contribution pension plans and other postretirement plans for its employees. The following tables provide the components of net periodic benefit cost for its major defined benefit plans and its other postretirement plans.
Pension Benefits
Three Months Ended September 30,
2009
2008
U.S.
Non-U.S.
U.S.
Non-U.S.
(In thousands)
Service cost
$
388
$
214
$
442
$
220
Interest cost
1,093
549
1,121
455
Expected return on plan assets
(876
)
(205
)
(1,292
)
(260
)
Net amortization
1,218
96
516
100
Net periodic benefit cost
$
1,823
$
654
$
787
$
515
17
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Pension Benefits
Nine Months Ended September 30,
2009
2008
U.S.
Non-U.S.
U.S.
Non-U.S.
(In thousands)
Service cost
$
1,164
$
609
$
1,324
$
674
Interest cost
3,281
1,562
3,363
1,394
Expected return on plan assets
(2,629
)
(577
)
(3,877
)
(801
)
Net amortization
3,654
273
1,549
304
Net periodic benefit cost
$
5,470
$
1,867
$
2,359
$
1,571
Other Postretirement Benefits
Nine Months Ended
Three Months Ended September 30,
September 30,
2009
2008
2009
2008
(In thousands)
Service cost
$
149
$
153
$
441
$
459
Interest cost
343
332
1,017
999
Net amortization
23
29
47
99
Net periodic benefit cost
$
515
$
514
$
1,505
$
1,557
The Company previously disclosed in its financial statements for the year ended December 31, 2008, that it expected to contribute approximately $11.7 million to its defined benefit plans and $1.3 million to its other postretirement benefit plans in 2009. As of September 30, 2009, $9.3 million of contributions have been made to the defined benefit plans and $0.7 million have been made to its other postretirement benefit plans. The Company presently anticipates contributing up to an additional $3.0 million in 2009 to fund these defined benefit and other postretirement benefit plans.
14.
Legal Proceedings
The Company is party to various legal proceedings arising in the ordinary course of business, none of which are expected to have a material adverse effect on its business, financial condition, results of operations or cash flows.
15.
Income Taxes
The Companys provision for income taxes is based upon estimated annual tax rates for the year applied to federal, state and foreign income. The provision for income taxes increased to $14.2 million in the third quarter of 2009 from $9.8 million in the third quarter of 2008. The effective tax rate decreased to 32.2% for the third quarter of 2009 compared to 33.0% in the third quarter of 2008 due to the mix of global pre-tax income among jurisdictions and unfavorable non-recurring discrete items in the third quarter of 2008.
The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction, and various state and foreign jurisdictions. Due to the potential for resolution of federal, state and foreign examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Companys gross unrecognized tax benefits balance may change within the next twelve months by a range of zero to $0.3 million.
18
Table of Contents
IDEX CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
16.
New Accounting Pronouncements
In October 2009, the FASB issued ASU
No. 2009-13,
Revenue Recognition (Topic 605) Multiple-Deliverable Revenue Arrangements. ASU
No. 2009-13
addresses the accounting for multiple-deliverable arrangements to enable vendors to account for products or services (deliverables) separately rather than as a combined unit. This guidance establishes a selling price hierarchy for determining the selling price of a deliverable, which is based on: (a) vendor-specific objective evidence; (b) third-party evidence; or (c) estimates. This guidance also eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method. In addition, this guidance significantly expands required disclosures related to a vendors multiple-deliverable revenue arrangements. ASU
No. 2009-13
is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 and early adoption is permitted. A company may elect, but will not be required, to adopt the amendments in ASU
No. 2009-13
retrospectively for all prior periods. Management is currently evaluating the requirements of ASU
No. 2009-13
and has not yet determined the impact on the Companys condensed consolidated financial statements.
In August 2009, the FASB issued ASU
2009-05,
Fair Value Measurements and Disclosures (Topic 820) Measuring Liabilities at Fair Value (Update
2009-05).
2009-05
provides clarification regarding valuation techniques when a quoted price in an active market for an identical liability is not available in addition to treatment of the existence of restrictions that prevent the transfer of a liability.
2009-05
also clarifies that both a quoted price in an active market for an identical liability at the measurement date and the quoted price for an identical liability when traded as an asset in an active market (when no adjustments to the quoted price of the asset are required) are Level 1 fair value measurements. This standard is effective for the first reporting period, including interim periods, beginning after issuance. Adoption of
2009-05
did not have a material effect on the consolidated financial position, results of operations or cash flows of the Company.
In December 2008, the FASB issued ASC 715 Compensation-Retirement Benefits. This standard provides additional guidance on employers disclosures about the plan assets of defined benefit pension or other postretirement plans. ASC 715 requires disclosures about how investment allocation decisions are made, the fair value of each major category of plan assets, valuation techniques used to develop fair value measurements of plan assets, the impact of measurements on changes in plan assets when using significant unobservable inputs and significant concentrations of risk in the plan assets. These disclosures are required for fiscal years ending after December 15, 2009. The Company is currently assessing the impact of this standard on its financial statement disclosures.
19
Table of Contents
Item 2.
Managements Discussion and Analysis of Financial Condition and Results of Operations.
Cautionary Statement Under the Private Securities Litigation Reform Act
The Historical Overview and the Liquidity and Capital Resources sections of this managements discussion and analysis of our financial condition and results of operations contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These statements may relate to, among other things, operating results and are indicated by words or phrases such as expects, should, will, and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this filing. The risks and uncertainties include, but are not limited to, IDEX Corporations (IDEX or the Company) ability to integrate and operate acquired businesses on a profitable basis and other risks and uncertainties identified under the heading Risk Factors included in item 1A of the Companys Annual Report on
Form 10-K
for the year ended December 31, 2008 and information contained in subsequent periodic reports filed by IDEX with the Securities and Exchange Commission. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented here.
Historical Overview
IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire, safety and other diversified products built to its customers specifications. Our products are sold in niche markets to a wide range of industries throughout the world. Accordingly, our businesses are affected by levels of industrial activity and economic conditions in the U.S. and in other countries where we do business and by the relationship of the U.S. dollar to other currencies. Levels of capacity utilization and capital spending in certain industries and overall industrial activity are among the factors that influence the demand for our products.
IDEX consists of four reportable segments: Fluid & Metering Technologies, Health & Science Technologies, Dispensing Equipment and Fire & Safety/Diversified Products.
The Fluid & Metering Technologies Segment produces pumps, compressors, flow meters and related controls for the movement of liquids and gases in a diverse range of end markets from industrial infrastructure to food and beverage; and provides metering technology and flow monitoring services for water and wastewater markets. The Health & Science Technologies Segment produces a wide variety of small scale, highly accurate pumps, valves, fittings and medical devices, as well as compressors used in medical, dental and industrial applications. The Dispensing Equipment Segment produces highly engineered equipment for dispensing, metering and mixing colorants, paints, inks and dyes, hair colorants and other personal care products, refinishing equipment, as well as the food industry. The Fire & Safety/Diversified Products Segment produces firefighting pumps, rescue tools, lifting bags and other components and systems for the fire and rescue industry; and engineered stainless steel banding and clamping devices used in a variety of industrial and commercial applications.
Results of Operations
On July 1, 2009 FASB ASC became the authoritative source of accounting principals to be applied to financial statements prepared in accordance with U.S. GAAP. In accordance with the ASC, citations to accounting literature in this report are to the relevant topic of the ASC or are presented in plain English.
The following is a discussion and analysis of our financial position and results of operations for the period ended September 30, 2009 and 2008. For purposes of this discussion and analysis section, reference is made to the table below and the Companys Condensed Consolidated Statements of Operations included in Item 1. As of January 1, 2009, we changed our method of accounting for inventory from the LIFO method to the FIFO method. Certain prior year amounts have been restated to reflect the LIFO to FIFO inventory costing change (see Note 5).
Performance in the Three Months Ended September 30, 2009 Compared with the Same Period of 2008
Sales in the three months ended September 30, 2009 were $323.2 million, a 12% decrease from the comparable period last year. This decrease reflects a 17% decrease in organic sales and 2% unfavorable foreign currency
20
Table of Contents
translation, partially offset by a 7% increase from four acquisitions (Richter October 2008, iPEK October 2008, IETG October 2008 and Semrock October 2008). Sales to international customers represented approximately 48% of total sales in the current period compared to 46% in the same period in 2008.
For the third quarter of 2009, Fluid & Metering Technologies contributed 48 percent of sales and 46 percent of operating income; Health & Science Technologies accounted for 24 percent of sales and 26 percent of operating income; Dispensing Equipment accounted for 8 percent of sales and 0 percent of operating income; and Fire & Safety/Diversified Products represented 20 percent of sales and 28 percent of operating income.
Fluid & Metering Technologies sales of $156.9 million for the three months ended September 30, 2009 declined $13.3 million, or 8% compared with 2008, reflecting a 19% decrease in organic growth and 1% unfavorable foreign currency translation, partially offset by a 12% increase for acquisitions (Richter, iPEK and IETG). The decrease in organic growth was driven by weakness in chemical, energy, water and waste water markets. In the third quarter of 2009, organic sales decreased approximately 23% domestically and 11% internationally. Organic business sales to customers outside the U.S. were approximately 41% of total segment sales during the third quarter of 2009 and 40% in 2008.
Health & Science Technologies sales of $76.1 million decreased $6.8 million, or 8% in the third quarter of 2009 compared with 2008. This reflects a 13% decrease in organic growth and 1% of unfavorable foreign currency translation, partially offset by a 6% increase from the acquisition of Semrock. The decrease in organic growth reflects market softness in non-core Health & Science Technologies businesses. In the third quarter of 2009, organic sales decreased 24% domestically and increased 4% internationally. Organic business sales to customers outside the U.S. were approximately 46% of total segment sales in the third quarter of 2009, compared to 38% in 2008.
Dispensing Equipment sales of $25.6 million decreased $6.0 million, or 19% in the third quarter of 2009 compared with 2008. This decrease reflects a 15% decrease in organic growth and 4% of unfavorable foreign currency translation. The decrease in organic growth was due to continued deterioration in capital spending in the European and North American markets. In the third quarter of 2009, organic sales decreased 29% domestically and 10% internationally. Organic sales to customers outside the U.S. were approximately 78% of total segment sales in the third quarter of 2009, compared with 72% in the comparable quarter of 2008.
Fire & Safety/Diversified Products sales of $65.5 million decreased $15.7 million, or 19% in the third quarter of 2009 compared with 2008. This change reflects a 16% decrease in organic business volume and 3% unfavorable foreign currency translation. The decrease in organic business growth was driven by lower demand for engineered band clamping systems and rescue equipment. In the third quarter of 2009, organic business sales decreased 12% domestically and 20% internationally. Organic sales to customers outside the U.S. were approximately 55% of total segment sales in the third quarter of 2009, compared to 56% in 2008.
21
Table of Contents
Three Months
Nine Months
Ended September 30,
Ended September 30,
2009
(1)
2008
(2)
2009
(1)
2008
(2)
Fluid & Metering Technologies
Net sales
$
156,939
$
170,258
$
470,957
$
518,546
Operating income
(3)
25,755
33,656
70,731
98,227
Operating margin
16.4
%
19.8
%
15.0
%
18.9
%
Depreciation and amortization
$
8,061
$
5,842
$
24,396
$
18,605
Capital expenditures
3,810
2,519
9,682
7,695
Health & Science Technologies
Net sales
$
76,138
$
82,889
$
224,142
$
253,778
Operating income
(3)
14,287
17,012
34,703
47,896
Operating margin
18.8
%
20.5
%
15.5
%
18.9
%
Depreciation and amortization
$
3,866
$
2,573
$
10,579
$
8,411
Capital expenditures
1,879
1,294
3,793
3,894
Dispensing Equipment
Net sales
$
25,580
$
31,543
$
104,111
$
138,152
Operating income (loss)
(3)(5)
(311
)
(32,026
)
13,112
(6,526
)
Operating margin
(5)
(1.2
)%
(101.5
)%
12.6
%
(4.7
)%
Depreciation and amortization
$
670
$
946
$
2,340
$
3,215
Capital expenditures
292
652
850
2,236
Fire & Safety/Diversified Products
Net sales
$
65,524
$
81,189
$
192,633
$
227,099
Operating income
(3)
15,932
20,401
42,790
56,959
Operating margin
24.3
%
25.1
%
22.2
%
25.1
%
Depreciation and amortization
$
1,287
$
1,206
$
3,815
$
3,950
Capital expenditures
853
789
2,569
3,929
Company
Net sales
$
323,249
$
365,193
$
986,317
$
1,134,165
Operating income
(3)
46,517
30,804
132,413
168,326
Operating margin
14.4
%
8.4
%
13.4
%
14.8
%
Depreciation and amortization
(4)
$
14,135
$
10,879
$
41,893
$
35,092
Capital expenditures
7,081
5,851
18,303
19,164
(1)
Data includes acquisition of Richter (October 2008), iPEK (October 2008) and IETG (October 2008) in the Fluid & Metering Technologies segment and Semrock (October 2008) in the Health & Science Technologies segment from the dates of acquisition.
(2)
Certain prior year amounts have been restated to reflect the LIFO to FIFO inventory costing change.
(3)
Group operating income excludes unallocated corporate operating expenses.
(4)
Excludes amortization of debt issuance expenses.
(5)
Segment operating income and margin includes $30.1 million goodwill impairment charge in 2008 for Fluid Management Americas.
Gross profit of $129.1 million in the third quarter of 2009 decreased $18.7 million, or 13% from 2008. Gross profit as a percent of sales was 39.9% in the third quarter of 2009 and 40.5% in 2008. The decrease in gross margin primarily reflects product mix as well as the impact of fixed cost expense from lower volume across most of our businesses.
22
Table of Contents
Selling, general and administrative (SG&A) expenses decreased to $79.8 million in the third quarter of 2009 from $81.6 million in 2008. The $1.8 million decrease reflects approximately $9.3 million for volume related expenses, partially offset by a $7.5 million increase for incremental costs associated with recently acquired businesses. As a percent of sales, SG&A expenses were 24.7% for 2009 and 22.3% for 2008.
During the three months ended September 30, 2009 and 2008, the Company recorded pre-tax restructuring expenses totaling $2.8 million and $5.3 million, respectively, for employee severance related to employee reductions across various functional areas and facility closures resulting from the Companys cost savings initiatives.
During the three months ended September 30, 2008 in accordance with ASC 350, the Company concluded that events had occurred and circumstances had changed which required the Company to perform an interim period goodwill impairment test at Fluid Management Americas, a reporting unit within the Companys Dispensing Equipment Segment. Fluid Management Americas had experienced a downturn in capital spending by its customer base and the loss of a major retail customer. The Company performed an impairment test and compared the fair value of the reporting unit to its carrying value. It was determined that the fair value of Fluid Management Americas was less than the carrying value of the net assets. The excess of the fair value of the reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. The Companys analysis resulted in an implied fair value of goodwill of $21.2 million, and as a result, the Company recognized an impairment charge of $30.1 million in the third quarter of 2008.
Operating income of $46.5 million and operating margins of 14.4% in the third quarter of 2009 were up from the $30.8 million and 8.4% recorded in 2008, primarily reflecting decreased expenses from previously announced restructuring-related charges and the goodwill impairment charge in 2008, partially offset by decreased volume. In the Fluid & Metering Technologies Segment, operating income of $25.8 million and operating margins of 16.4% in the third quarter of 2009 were down from the $33.7 million and 19.8% recorded in 2008 principally due to the impact of recent acquisitions and lower sales. In the Health & Science Technologies Segment, operating income of $14.3 million and operating margins of 18.8% in the third quarter of 2009 were down from the $17.0 million and 20.5% recorded in 2008 due to lower volume. In the Dispensing Equipment Segment, operating loss of $0.3 million and operating margins of (1.2)% in the third quarter of 2009 were up from the $32.0 million operating loss in 2008, due primarily to goodwill impairment charges in 2008, partially offset by lower volumes in the North American and European markets. Operating income and operating margins in the Fire & Safety/Diversified Products Segment of $15.9 million and 24.3%, respectively, were lower than the $20.4 million and 25.1% recorded in 2008, due primarily to lower volume and unfavorable product mix.
The provision for income taxes is based upon estimated annual tax rates for the year applied to federal, state and foreign income. The provision for income taxes increased to $14.2 million in the third quarter of 2009 compared to the third quarter of 2008, which was $9.8 million. The effective tax rate decreased to 32.2% for the third quarter of 2009 compared to 33.0% in the third quarter of 2008 due to the mix of global pre-tax income among jurisdictions.
Net income for the current quarter of $29.8 million increased from the $19.9 million earned in the third quarter of 2008. Diluted earnings per share in the third quarter of 2009 of $0.37 increased $0.13, or 54%, compared with the third quarter of 2008.
Performance in the Nine Months Ended September 30, 2009 Compared with the Same Period of 2008
Sales in the nine months ended September 30, 2009 were $986.3 million, a 13% decrease from the comparable period last year. This decrease reflects a 16% decrease in organic sales and 3% unfavorable foreign currency translation, partially offset by a 6% increase from four acquisitions (Richter October 2008, iPEK October 2008, IETG October 2008 and Semrock October 2008). Sales to international customers represented approximately 46% of total sales in the current period compared to 47% in the same period in 2008.
For the first nine months of 2009, Fluid & Metering Technologies contributed 48 percent of sales and 44 percent of operating income; Health & Science Technologies accounted for 23 percent of sales and 22 percent of operating income; Dispensing Equipment accounted for 10 percent of sales and 8 percent of operating income; and Fire & Safety/Diversified Products represented 19 percent of sales and 26 percent of operating income.
23
Table of Contents
Fluid & Metering Technologies sales of $471.0 million for the nine months ended September 30, 2009 declined $47.6 million, or 9% compared with 2008, reflecting a 19% decrease in organic growth and 2% unfavorable foreign currency translation, partially offset by a 12% increase for acquisitions (Richter, iPEK and IETG). The decrease in organic growth was driven by weakness in chemical, energy, water and waste water markets. In the first nine months of 2009, organic sales decreased approximately 19% domestically and 17% internationally. Organic business sales to customers outside the U.S. were approximately 40% of total segment sales during the first nine months of 2009, compared to 42% in 2008.
Health & Science Technologies sales of $224.1 million decreased $29.6 million, or 12% in the first nine months of 2009 compared with 2008. This reflects a 16% decrease in organic growth and 2% of unfavorable foreign currency translation, partially offset by a 6% increase from the acquisition of Semrock. The organic decline reflects significant market softness in non-core Health & Science Technologies businesses. In the first nine months of 2009, organic sales decreased 16% domestically and 15% internationally. Organic business sales to customers outside the U.S. were approximately 40% of total segment sales in the first nine months of 2009, compared to 39% in 2008.
Dispensing Equipment sales of $104.1 million decreased $34.0 million, or 25% in the first nine months of 2009 compared with 2008. This decrease reflects a 19% decrease in organic growth and 6% of unfavorable foreign currency translation. The decrease in organic growth was due to continued deterioration in capital spending in the European and North American markets, partially offset by one large replenishment project in the North American market. In the first nine months of 2009, organic sales increased 13% domestically and decreased 30% internationally. Organic sales to customers outside the U.S. were approximately 64% of total segment sales in the first nine months of 2009, compared with 72% in the comparable period of 2008.
Fire & Safety/Diversified Products sales of $192.6 million decreased $34.5 million, or 15% in the first nine months of 2009 compared with 2008. This change reflects a 9% decrease in organic business volume and 6% unfavorable foreign currency translation. The decrease in organic business growth was driven by lower demand for engineered band clamping systems and rescue equipment. In the first nine months of 2009, organic business sales decreased 11% domestically and 8% internationally. Organic sales to customers outside the U.S. were approximately 55% of total segment sales in the first nine months of 2009, compared to 56% in 2008.
Gross profit of $383.4 million in the first nine months of 2009 decreased $78.4 million, or 17% from 2008. Gross profit as a percent of sales was 38.9% in the first nine months of 2009 and 40.7% in 2008. The decrease in gross margin primarily reflects product mix, inventory fair value expense as well as the impact of fixed cost absorption from lower volume across most of our businesses.
SG&A expenses decreased to $242.7 million in the first nine months of 2009 from $258.1 million in 2008. The $15.4 million decrease reflects approximately $37.2 million for volume related expenses, partially offset by a $21.8 million increase for incremental costs associated with recently acquired businesses. As a percent of sales, SG&A expenses were 24.6% for 2009 and 22.8% for 2008.
During the nine months ended September 30, 2009 and 2008, the Company recorded pre-tax restructuring expenses totaling $8.3 million and $5.3 million, respectively, for employee severance related to employee reductions across various functional areas and facility closures resulting from the Companys cost savings initiatives.
During the first nine months of 2008 in accordance with ASC 350, the Company concluded that events had occurred and circumstances had changed which required the Company to perform an interim period goodwill impairment test at Fluid Management Americas, a reporting unit within the Companys Dispensing Equipment Segment. Fluid Management Americas had experienced a downturn in capital spending by its customer base and the loss of a major retail customer. The Company performed an impairment test and compared the fair value of the reporting unit to its carrying value. It was determined that the fair value of Fluid Management Americas was less than the carrying value of the net assets. The excess of the fair value of the reporting unit over the amounts assigned to its assets and liabilities is the implied fair value of goodwill. The Companys analysis resulted in an implied fair value of goodwill of $21.2 million, and as a result, the Company recognized an impairment charge of $30.1 million in the first nine months of 2008.
24
Table of Contents
Operating income of $132.4 million and operating margins of 13.4% in the first nine months of 2009 were down from the $168.3 million and 14.8% recorded in 2008, primarily reflecting increased expenses from previously announced restructuring-related charges, impact from acquisitions and a decrease in volume, partially offset by the goodwill impairment charge in 2008. In the Fluid & Metering Technologies Segment, operating income of $70.7 million and operating margins of 15.0% in the first nine months of 2009 were down from the $98.2 million and 18.9% recorded in 2008 principally due to the impact of recent acquisitions and lower sales. In the Health & Science Technologies Segment, operating income of $34.7 million and operating margins of 15.5% in the first nine months of 2009 were down from the $47.9 million and 18.9% recorded in 2008 due to lower volume. In the Dispensing Equipment Segment, operating income of $13.1 million and operating margins of 12.6% in the first nine months of 2009 were up from the $6.5 million of operating loss and recorded in 2008, due to a goodwill impairment charge in 2008, partially offset by continued deterioration in the North American and European markets. Operating income and operating margins in the Fire & Safety/Diversified Products Segment of $42.8 million and 22.2%, respectively, were lower than the $57.0 million and 25.1% recorded in 2008, due primarily to lower volume and unfavorable product mix.
The provision for income taxes is based upon estimated annual tax rates for the year applied to federal, state and foreign income. The provision for income taxes decreased to $39.7 million in the first nine months of 2009 compared to the same period of 2008, which was $54.0 million. The effective tax rate of 33.1% in the first nine months of 2009 was lower compared to 34.1% in the same period of 2008 due to the mix of global pre-tax income among jurisdictions.
Net income for the current period of $80.3 million decreased from the $104.5 million earned in the first nine months of 2008. Diluted earnings per share in the first nine months of 2009 of $0.99 decreased $0.27, or 21%, compared with the first nine months of 2008.
Liquidity and Capital Resources
At September 30, 2009, working capital was $251.7 million and our current ratio was 2.2 to 1. Cash flows from operating activities decreased $10.4 million, or 6%, to $157.7 million in the first nine months of 2009 mainly due to reduced volume and restructuring-related payments.
Cash flows provided by operations were more than adequate to fund capital expenditures of $18.3 million and $19.1 million in the first nine months of 2009 and 2008, respectively. Capital expenditures were generally for machinery and equipment that improved productivity and tooling to support the global sourcing initiatives, although a portion was for business system technology and replacement of equipment and facilities. Management believes that the Company has ample capacity in its plants and equipment to meet expected needs for future growth in the intermediate term.
The Company maintains a $600.0 million unsecured domestic, multi-currency bank revolving credit facility, which expires on December 21, 2011. At September 30, 2009 there was $347.7 million outstanding under the Credit Facility and outstanding letters of credit totaled approximately $7.1 million. The net available borrowing under the Credit Facility as of September 30, 2009, was approximately $245.2 million. Interest is payable quarterly on the outstanding borrowings at the bank agents reference rate. Interest on borrowings based on LIBOR plus an applicable margin is payable on the maturity date of the borrowing, or quarterly from the effective date for borrowings exceeding three months. The applicable margin is based on the Companys senior, unsecured, long-term debt rating and can range from 24 basis points to 50 basis points. Based on the Companys BBB rating at September 30, 2009, the applicable margin was 40 basis points. An annual Credit Facility fee, also based on the Companys credit rating, is currently 10 basis points and is payable quarterly.
At September 30, 2009 the Company has one interest rate exchange agreement related to the Credit Facility. The interest rate exchange agreement, expiring in January 2011, effectively converted $250.0 million of floating-rate debt into fixed-rate debt at an interest rate of 3.25%. The fixed rate noted above is comprised of the fixed rate on the interest rate exchange agreement and the Companys current margin of 40 basis points on the Credit Facility.
On April 18, 2008, the Company completed a $100.0 million unsecured senior bank term loan agreement, with covenants consistent with the existing Credit Facility and a maturity on December 21, 2011. At September 30, 2009,
25
Table of Contents
there was $95.0 million outstanding under the Term Loan with $5.0 million included within short term borrowings. Interest under the Term Loan is based on the bank agents reference rate or LIBOR plus an applicable margin and is payable at the end of the selected interest period, but at least quarterly. The applicable margin is based on the Companys senior, unsecured, long-term debt rating and can range from 45 to 100 basis points. Based on the Companys current debt rating, the applicable margin is 80 basis points. The Term Loan requires repayments of $5.0 million and $7.5 million in April of 2010 and 2011, respectively, with the remaining balance due on December 21, 2011. The Company used the proceeds from the Term Loan to pay down existing debt outstanding under the Credit Facility. At September 30, 2009 the Company has an interest rate exchange agreement related to the Term Loan that expires December 2011. With a current notional amount of $95.0 million, the agreement effectively converted $100.0 million of floating-rate debt into fixed-rate debt at an interest rate of 4.00%. The fixed rate is comprised of the fixed rate on the interest rate exchange agreement and the Companys current margin of 80 basis points on the Term Loan.
On April 21, 2008, the Companys Board of Directors authorized the repurchase of up to $125.0 million of its outstanding common shares. Repurchases under the new program will be funded with cash flow generation, and made from time to time in either the open market or through private transactions. The timing, volume, and nature of share repurchases will be at the discretion of management, dependent on market conditions, other priorities for cash investment, applicable securities laws, and other factors, and may be suspended or discontinued at any time. Since inception of the repurchase program, 2.3 million shares have been purchased at a cost of $50.0 million; no shares have been purchased during the first nine months of 2009.
Despite the current downturn in global financial markets, the Company has not experienced any liquidity issues and we continue to expect that our current liquidity, notwithstanding these adverse market conditions, will be sufficient to meet our operating requirements, interest on all borrowings, required debt repayments, any authorized share repurchases, planned capital expenditures, and annual dividend payments to holders of common stock during the next twelve months. In the event that suitable businesses are available for acquisition upon terms acceptable to the Board of Directors, we may obtain all or a portion of the financing for the acquisitions through the incurrence of additional long-term borrowings. However, in light of recent adverse events in global financial and economic conditions, we cannot be certain that additional financing will be available on satisfactory terms, if at all.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
The Company is subject to market risk associated with changes in foreign currency exchange rates and interest rates. We may, from time to time, enter into foreign currency forward contracts and interest rate exchange agreements on our debt when we believe there is a financial advantage in doing so. A treasury risk management policy, adopted by the Board of Directors, describes the procedures and controls over derivative financial and commodity instruments, including foreign currency forward contracts and interest rate swaps. Under the policy, we do not use derivative financial or commodity instruments for trading purposes, and the use of these instruments is subject to strict approvals by senior officers. Typically, the use of derivative instruments is limited to foreign currency forward contracts and interest rate exchange agreements on the Companys outstanding long-term debt. The Companys exposure related to derivative instruments is, in the aggregate, not material to its financial position, results of operations or cash flows.
The Companys foreign currency exchange rate risk is limited principally to the Euro, British Pound, Canadian Dollar and Chinese Renminbi. We manage our foreign exchange risk principally through invoicing our customers in the same currency as the source of our products. The effect of transaction gains and losses is reported within Other income (expense)-net on the Condensed Consolidated Statements of Operations. At September 30, 2009 the Company had foreign currency contracts with an aggregate notional amount of $3.4 million.
The Companys interest rate exposure is primarily related to the $447.1 million of total debt outstanding at September 30, 2009. The majority of the debt is priced at interest rates that float with the market. In order to mitigate this interest exposure, the Company entered into interest rate exchange agreements that effectively converted $345.0 million of our floating-rate debt outstanding at September 30, 2009 to a fixed-rate. A 50-basis point movement in the interest rate on the remaining $102.1 million floating-rate debt would result in an approximate $0.5 million annualized increase or decrease in interest expense and cash flows.
26
Table of Contents
Item 4.
Controls and Procedures.
The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Companys Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to the Companys management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As required by SEC
Rule 13a-15(b),
the Company carried out an evaluation, under the supervision and with the participation of the Companys management, including the Companys Chief Executive Officer and the Companys Chief Financial Officer, of the effectiveness of the design and operation of the Companys disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, the Companys Chief Executive Officer and Chief Financial Officer concluded that the Companys disclosure controls and procedures were effective.
There has been no change in the Companys internal controls over financial reporting during the Companys most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Companys internal controls over financial reporting.
27
Table of Contents
PART II. OTHER INFORMATION
Item 1.
Legal Proceedings.
The Company and six of its subsidiaries are presently named as defendants in a number of lawsuits claiming various asbestos-related personal injuries, allegedly as a result of exposure to products manufactured with components that contained asbestos. Such components were acquired from third party suppliers, and were not manufactured by any of the subsidiaries. To date, the majority of the Companys settlements and legal costs, except for costs of coordination, administration, insurance investigation and a portion of defense costs, have been covered in full by insurance subject to applicable deductibles. However, the Company cannot predict whether and to what extent insurance will be available to continue to cover such settlements and legal costs, or how insurers may respond to claims that are tendered to them.
Claims have been filed in jurisdictions throughout the United States. Most of the claims resolved to date have been dismissed without payment. The balance have been settled for various insignificant amounts. Only one case has been tried, resulting in a verdict for the Companys business unit.
No provision has been made in the financial statements of the Company, other than for insurance deductibles in the ordinary course, and the Company does not currently believe the asbestos-related claims will have a material adverse effect on the Companys business, financial position, results of operations or cash flow.
The Company is also party to various other legal proceedings arising in the ordinary course of business, none of which is expected to have a material adverse effect on its business, financial condition, results of operations or cash flow.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
Total Number of
Maximum Dollar
Shares Purchased as
Value that May Yet
Part of Publicly
be Purchased
Total Number of
Average Price
Announced Plans
Under the Plans
Period
Shares Purchased
Paid per Share
or Programs
(1)
or Programs
(1)
July 1, 2009 to
July 31, 2009
$
75,000,020
August 1, 2009 to
August 31, 2009
$
75,000,020
September 1, 2009 to
September 30, 2009
$
75,000,020
Total
$
75,000,020
(1)
On April 21, 2008, IDEXs Board of Directors authorized the repurchase of up to $125.0 million of its outstanding common shares either in the open market or through private transactions.
Item 5.
Other Information.
There has been no material change to the procedures by which security holders may recommend nominees to the Companys board.
Item 6.
Exhibits.
The exhibits listed in the accompanying Exhibit Index are filed as part of this report.
28
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
IDEX Corporation
/s/
Dominic A. Romeo
Dominic A. Romeo
Vice President and Chief Financial Officer
(duly authorized principal financial officer)
November 4, 2009
29
Table of Contents
EXHIBIT INDEX
Exhibit
Number
Description
3
.1
Restated Certificate of Incorporation of IDEX Corporation (formerly HI, Inc.) (incorporated by reference to Exhibit No. 3.1 to the Registration Statement on
Form S-1
of IDEX, et al., Registration
No. 33-21205,
as filed on April 21, 1988)
3
.1(a)
Amendment to Restated Certificate of Incorporation of IDEX Corporation (formerly HI, Inc.), (incorporated by reference to Exhibit No. 3.1(a) to the Quarterly Report of IDEX on
Form 10-Q
for the quarter ended March 31, 1996, Commission File
No. 1-10235)
3
.1(b)
Amendment to Restated Certificate of Incorporation of IDEX Corporation (incorporated by reference to Exhibit No. 3.1(b) to the Current Report of IDEX on
Form 8-K
dated March 24, 2005, Commission File
No. 1-10235)
3
.2
Amended and Restated By-Laws of IDEX Corporation (incorporated by reference to Exhibit No. 3.2 to Post-Effective Amendment No. 2 to the Registration Statement on
Form S-1
of IDEX, et al., Registration
No. 33-21205,
as filed on July 17, 1989)
3
.2(a)
Amended and Restated Article III, Section 13 of the Amended and Restated By-Laws of IDEX Corporation (incorporated by reference to Exhibit No. 3.2(a) to Post-Effective Amendment No. 3 to the Registration Statement on
Form S-1
of IDEX, et al., Registration
No. 33-21205,
as filed on February 12, 1990)
4
.1
Restated Certificate of Incorporation and By-Laws of IDEX Corporation (filed as Exhibits No. 3.1 through 3.2(a))
4
.2
Specimen Certificate of Common Stock of IDEX Corporation (incorporated by reference to Exhibit No. 4.3 to the Registration Statement on
Form S-2
of IDEX, et al., Registration
No. 33-42208,
as filed on September 16, 1991)
4
.3
Credit Agreement, dated as of December 21, 2006, among IDEX Corporation, Bank of America N.A. as Agent and Issuing Bank, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 10.1 to the Current Report of IDEX on
Form 8-K
dated December 22, 2006, Commission File
No. 1-10235)
4
.3(a)
Amendment No. 2 to Credit Agreement, dated as of September 29, 2008, among IDEX Corporation, Bank of America N.A. as Agent and Issuing Bank, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 4.3(a) to the Quarterly Report of IDEX on
Form 10-Q
for the quarter ended September 30, 2008, Commission File
No. 1-10235)
4
.4
Term Loan Agreement, dated April 18, 2008, among IDEX Corporation, Bank of America N.A. as Agent, and the other financial institutions party hereto (incorporated by reference to Exhibit No. 10.1 to the Current Report of IDEX on
Form 8-K
dated April 18, 2008, Commission File
No. 1-10235)
18
Letter from Deloitte and Touche, LLP regarding change in accounting principle hereto (incorporated by reference to Exhibit No. 18 to the Quarterly Report of IDEX on
Form 10-Q
for the quarter ended March 31, 2009, Commission File
No. 1-10235)
*31
.1
Certification of Chief Executive Officer Pursuant to
Rule 13a-14(a)
or
Rule 15d-14(a)
*31
.2
Certification of Chief Financial Officer Pursuant to
Rule 13a-14(a)
or
Rule 15d-14(a)
*32
.1
Certification pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code
*32
.2
Certification pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code
*
Filed herewith
30